CHAC1 and urinary bladder carcinoma: For example, Yu et al. (2024) showed that treating bladder cancer cells with the anti-tumor compound brusatol boosted CHAC1 expression while simultaneously lowering SLC7A11 and NRF2 levels (Yu et al., 2024).